Core Scientific’s (CORZ) Overweight Rating Reaffirmed at Cantor Fitzgerald

Core Scientific (NASDAQ:CORZ)‘s stock had its “overweight” rating restated by equities researchers at Cantor Fitzgerald in a research report issued to clients and investors on Wednesday, Benzinga reports. They presently have a $39.00 target price on the stock. Cantor Fitzgerald’s target price would indicate a potential upside of 189.62% from the company’s previous close.

CORZ has been the subject of a number of other research reports. Needham & Company LLC lifted their price objective on Core Scientific from $29.00 to $35.00 and gave the stock a “buy” rating in a research report on Wednesday, July 29th. Canaccord Genuity Group lifted their price objective on Core Scientific from $30.00 to $36.00 and gave the company a “buy” rating in a research note on Wednesday, July 29th. BTIG Research reaffirmed a “buy” rating and issued a $38.00 price objective on shares of Core Scientific in a research note on Tuesday, July 28th. Wolfe Research restated a “buy” rating on shares of Core Scientific in a report on Wednesday, July 29th. Finally, Keefe, Bruyette & Woods raised Core Scientific from a “market perform” rating to an “outperform” rating and upped their price target for the company from $25.00 to $28.00 in a research report on Thursday, July 30th. Two equities research analysts have rated the stock with a Strong Buy rating, eighteen have issued a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Core Scientific presently has an average rating of “Moderate Buy” and an average target price of $31.36.

Core Scientific Trading Down 6.8%

Shares of CORZ stock traded down $0.98 during mid-day trading on Wednesday, reaching $13.47. The stock had a trading volume of 14,410,443 shares, compared to its average volume of 12,700,181. Core Scientific has a 12-month low of $12.31 and a 12-month high of $30.46. The company has a market cap of $4.33 billion, a P/E ratio of -3.04 and a beta of 5.49. The business has a 50-day simple moving average of $17.45 and a 200 day simple moving average of $21.05.

Core Scientific (NASDAQ:CORZ) last announced its quarterly earnings results on Tuesday, July 28th. The company reported ($3.32) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.06) by ($3.26). The firm had revenue of $164.20 million during the quarter, compared to analyst estimates of $144.83 million. Research analysts anticipate that Core Scientific will post -1.36 EPS for the current year.

Insiders Place Their Bets

In other Core Scientific news, insider Todd DuChene sold 10,000 shares of the stock in a transaction on Monday, October 12th. The stock was sold at an average price of $15.12, for a total value of $151,200.00. Following the sale, the insider directly owned 1,159,668 shares of the company’s stock, valued at $17,534,180.16. This trade represents a 0.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Eric Weiss bought 6,000 shares of the company’s stock in a transaction on Tuesday, September 15th. The stock was bought at an average cost of $16.33 per share, for a total transaction of $97,980.00. Following the completion of the transaction, the director directly owned 265,262 shares of the company’s stock, valued at $4,331,728.46. This trade represents a 2.31% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last three months, insiders have purchased 19,000 shares of company stock valued at $342,290 and have sold 100,000 shares valued at $1,881,300. 1.70% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Core Scientific

Large investors have recently added to or reduced their stakes in the stock. BlackRock Inc. acquired a new stake in Core Scientific in the second quarter worth $719,649,000. Jericho Capital Asset Management L.P. lifted its holdings in Core Scientific by 11.4% in the fourth quarter. Jericho Capital Asset Management L.P. now owns 13,038,619 shares of the company’s stock worth $189,842,000 after purchasing an additional 1,338,796 shares during the period. Apollo Management Holdings L.P. acquired a new stake in Core Scientific in the second quarter worth about $115,671,000. Avala Global LP acquired a new position in Core Scientific during the second quarter worth about $101,729,000. Finally, Bank of America Corp DE acquired a new position in Core Scientific during the second quarter worth about $93,668,000.

More Core Scientific News

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Analysts remain optimistic about Core Scientific’s long-term growth. Cantor Fitzgerald reaffirmed its “Overweight” rating, while Canaccord Genuity and BTIG Research reiterated “Buy” ratings with price targets of $36 and $38, respectively—well above recent trading levels. Cantor Fitzgerald Reaffirms Overweight Rating for Core Scientific
• Positive Sentiment: Core Scientific’s shares recently rallied on above-average volume, indicating strong trading interest. However, Zacks cautioned that recent earnings-estimate revisions may not be sufficient to sustain additional near-term gains. Strength Seen in Core Scientific
• Neutral Sentiment: The company will report third-quarter 2026 results before the market opens on November 5 and hold a conference call afterward. The upcoming report is a potential catalyst, particularly given its last quarterly loss substantially exceeded analyst expectations despite revenue beating estimates. Core Scientific Schedules Third-Quarter Earnings Release
• Negative Sentiment: Investors are again rotating away from debt-heavy AI data-center developers, pressuring companies such as Core Scientific, Applied Digital and TeraWulf. The sentiment reflects concern about leverage and high valuations across the AI infrastructure sector. Rotation Out of Debt-Funded AI Builders
• Negative Sentiment: Insider Todd DuChene sold 10,000 shares for approximately $151,200, reducing his position by 0.85%. Although the remaining ownership is substantial, the transaction adds a modest negative signal.

About Core Scientific

Core Scientific, Inc is a digital infrastructure company that develops and operates data centers in the United States. Its business has historically centered on cryptocurrency mining, particularly the processing of transactions on the Bitcoin network, while also providing hosting and infrastructure services to other mining and technology customers.

The company is expanding its data center capabilities to support high-performance computing and artificial intelligence workloads. Its services include data center operations, power and equipment management, hosting, and related infrastructure support for customers that require substantial computing capacity.

Core Scientific was founded in 2017 and became a publicly traded company through a business combination in 2022.